A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low dose oral contraceptive containing 20 μg ethinyl estradiol and 100 μg levonorgestrel over six treatment cycles
- 30 November 1997
- journal article
- Published by Elsevier in Contraception
- Vol. 56 (5) , 285-290
- https://doi.org/10.1016/s0010-7824(97)00157-1
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Inhibition of ovulation by an oral contraceptive containing 100 μg levonorgestrel in combination with 20 μg ethinylestradiolContraception, 1996
- A three-year clinical investigation into efficacy, cycle control and tolerability of a new low-dose monophasic oral contraceptive containing gestodeneGynecological Endocrinology, 1996
- A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 μg ethinylestradiol/75 μg gestodene and 20 μg ethinylestradiol/150 μg desogestrel, with respect to efficacy, cycle control and toleranceContraception, 1995
- Efficacy and safety of a monophasic and a triphasic oral contraceptive containing norgestimateAmerican Journal of Obstetrics and Gynecology, 1994
- Clinical comparison of two low-dose oral contraceptives, Minulet® and Mercilon®, in women over 30 years of ageContraception, 1994
- A review of ‘once-a-month's combined injectable contraceptivesJournal of Obstetrics and Gynaecology, 1994
- Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 μg desogestrel and either 30 μg or 20 μg ethinyl oestradiolBJOG: An International Journal of Obstetrics and Gynaecology, 1993
- Oral contraceptives and cycle control: A critical review of the literatureAdvances in Contraception, 1992
- EFFICACY OF DIFFERENT CONTRACEPTIVE METHODSThe Lancet, 1982
- Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of DrugsBMJ, 1970